Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Roquefort Investments PLC ( (GB:ROQ) ) is now available.
Roquefort Therapeutics PLC has announced a live interactive investor presentation scheduled for 29 September 2025. The presentation will discuss the proposed acquisition of Coiled Therapeutics, Inc. and its AO-252 clinical stage program from A2A Pharmaceuticals, Inc., potentially impacting the company’s strategic positioning in the biotech industry.
More about Roquefort Investments PLC
Roquefort Therapeutics PLC is a biotech company listed on the Main Market, focusing on innovative therapeutic solutions.
Average Trading Volume: 1,715,687
Technical Sentiment Signal: Sell
Current Market Cap: £2.83M
See more data about ROQ stock on TipRanks’ Stock Analysis page.